Compare TARS & BOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARS | BOH |
|---|---|---|
| Founded | 2016 | 1897 |
| Country | United States | United States |
| Employees | N/A | 1877 |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2020 | N/A |
| Metric | TARS | BOH |
|---|---|---|
| Price | $65.71 | $80.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $89.00 | $82.40 |
| AVG Volume (30 Days) | ★ 414.5K | 293.4K |
| Earning Date | 05-05-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $56.56 | $15.66 |
| Revenue Next Year | $29.94 | $7.82 |
| P/E Ratio | ★ N/A | $17.08 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $59.36 |
| 52 Week High | $85.25 | $81.29 |
| Indicator | TARS | BOH |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 65.42 |
| Support Level | $65.62 | $69.76 |
| Resistance Level | $67.70 | N/A |
| Average True Range (ATR) | 3.04 | 1.91 |
| MACD | -0.37 | 0.44 |
| Stochastic Oscillator | 12.62 | 71.23 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.